Grab The Forge codes and bag yourself some rerolls to earn the sharpest gear possible in this mammoth mining adventure.
The Forge has quite a lot of depth (sorry), and while your weapon and pickaxe are crucial for picking up the best resources ...
VaporTheGamer reacts to tricky mod phase 4 song complete! [part 2] with fun commentary, unique insights, and FNAF or FNF fan excitement. ‘Send Them Back’: Trump Erupts Over TPS 3 children among 4 ...
Last week Apple launched a new feature for iOS 26.1 users: Digital ID in Apple Wallet. Here’s why the new feature could become a gift that keeps giving. Digital ID could help Apple’s Wallet dream ...
This week the company announced that it would require users to undergo an A.I.-powered age estimation process in order to chat with others on the platform. Will this change reassure parents? By Kevin ...
Roblox, the online gaming platform that has been under fire due to child safety concerns, has introduced age-verification software that uses facial scanning to estimate the age of players. The system ...
Following a spate of lawsuits and investigations over its child safety systems, Roblox is going to implement mandatory facial verification for all users who want to access communication features, ...
Roblox has rolled out the next phase of its licensing platform, which launched earlier this year. The firm has now made its license manager a self-serve platform for intellectual property holders.
On Wednesday, OpenAI released GPT-5.1 Instant and GPT-5.1 Thinking, two updated versions of its flagship AI models now available in ChatGPT. The company is wrapping the models in the language of ...
Angiopoietin-like protein 3 (ANGPTL3) inhibits lipoprotein and endothelial lipases. ANGPTL3 loss-of-function genetic variants are associated with decreased levels of low-density lipoprotein ...
The biggest stories of the day delivered to your inbox.
Results from pritelivir Phase 2 study demonstrate a favorable safety profile and a numerically higher lesion healing rate vs. foscarnet Pritelivir Phase 2 results supported FDA Breakthrough Therapy ...